| Rank | Logo | Name | Ticker | Market Cap | Price | Today % | Country |
|---|---|---|---|---|---|---|---|
| 1 |
|
Eli Lilly | LLY | $637.81 B | $711.48 | 0.86% | USA |
| 2 |
|
Johnson & Johnson | JNJ | $432.13 B | $179.43 | 0.33% | USA |
| 3 |
|
AbbVie | ABBV | $370.72 B | $209.86 | 0.34% | USA |
| 4 |
|
Roche | ROG.SW | $260.18 B | $324.71 | 0.04% | Switzerland |
| 5 |
|
AstraZeneca | AZN | $249.77 B | $80.56 | 0.05% | UK |
| 6 |
|
Novartis | NVS | $245.96 B | $127.06 | 0.15% | Switzerland |
| 7 |
|
Novo Nordisk | NVO | $244.45 B | $55.42 | 2.07% | Denmark |
| 8 |
|
Merck | MRK | $215.30 B | $86.20 | 1.82% | USA |
| 9 |
|
Amgen | AMGN | $159.67 B | $296.59 | 0.05% | USA |
| 10 |
|
Pfizer | PFE | $146.55 B | $25.78 | 1.57% | USA |
| 11 |
|
Gilead Sciences | GILD | $144.72 B | $116.64 | 1.76% | USA |
| 12 |
|
Sanofi | SNY | $123.47 B | $50.62 | 0.19% | France |
| 13 |
|
Vertex Pharmaceuticals | VRTX | $102.22 B | $398.70 | 1.10% | USA |
| 14 |
|
Bristol-Myers Squibb | BMY | $98.72 B | $48.50 | 0.51% | USA |
| 15 |
|
CVS Health | CVS | $91.07 B | $71.80 | 1.39% | USA |
| 16 |
|
GlaxoSmithKline | GSK | $80.91 B | $40.16 | 0.21% | UK |
| 17 |
|
CSL | CSL.AX | $70.33 B | $145.26 | 2.38% | Australia |
| 18 |
|
Chugai Pharmaceutical | 4519.T | $69.92 B | $42.49 | 2.10% | Japan |
| 19 |
|
Zoetis | ZTS | $69.04 B | $155.79 | 0.62% | USA |
| 20 |
|
Regeneron Pharmaceuticals | REGN | $63.59 B | $600.05 | 1.53% | USA |
| 21 |
|
Alnylam Pharmaceuticals | ALNY | $60.79 B | $463.83 | 1.20% | USA |
| 22 |
|
Jiangsu Hengrui Medicine | 600276.SS | $59.50 B | $8.91 | 1.81% | China |
| 23 |
|
Merck KGaA | MRK.DE | $55.46 B | $128.38 | 1.03% | Germany |
| 24 |
|
Lonza | LONN.SW | $49.19 B | $701.37 | 0.91% | Switzerland |
| 25 |
|
Takeda Pharmaceutical | TAK | $48.38 B | $15.32 | 1.03% | Japan |
| 26 |
|
Daiichi Sankyō | 4568.T | $46.60 B | $25.02 | 7.18% | Japan |
| 27 |
|
Sun Pharmaceutical | SUNPHARMA.NS | $45.08 B | $18.79 | 0.43% | India |
| 28 |
|
UCB | UCB.VI | $43.93 B | $231.26 | 2.18% | Belgium |
| 29 |
|
Argenx | ARGX | $40.54 B | $662.49 | 0.23% | Netherlands |
| 30 |
|
Galderma Group | GALD.SW | $39.64 B | $168.85 | 2.55% | Switzerland |
| 31 |
|
WuXi AppTec | 2359.HK | $38.17 B | $13.11 | 1.09% | China |
| 32 |
|
BeOne Medicines | ONC | $38.14 B | $313.84 | 1.46% | USA |
| 33 |
|
Bayer | BAYN.DE | $32.26 B | $32.68 | 0.63% | Germany |
| 34 |
|
Otsuka Holdings | 4578.T | $28.50 B | $53.98 | 0.85% | Japan |
| 35 |
|
Hansoh Pharma | 3692.HK | $27.88 B | $4.69 | 1.89% | China |
| 36 |
|
Insmed | INSM | $27.82 B | $131.66 | 1.71% | USA |
| 37 |
|
Celltrion | 068270.KS | $27.68 B | $122.27 | 0.41% | S. Korea |
| 38 |
|
BioNTech | BNTX | $26.62 B | $110.76 | 0.49% | Germany |
| 39 |
|
Sandoz Group | SDZ.SW | $26.22 B | $60.88 | 1.01% | Switzerland |
| 40 |
|
LabCorp | LH | $23.09 B | $277.94 | 0.06% | USA |
| 41 |
|
Innovent Biologics | 1801.HK | $21.72 B | $12.71 | 4.91% | China |
| 42 |
|
Teva Pharmaceutical Industries | TEVA | $21.47 B | $18.70 | 6.16% | Israel |
| 43 |
|
Royalty Pharma | RPRX | $21.14 B | $36.25 | 1.71% | UK |
| 44 |
|
Biogen | BIIB | $20.33 B | $138.71 | 0.20% | USA |
| 45 |
|
Astellas Pharma | 4503.T | $20.25 B | $11.31 | 1.12% | Japan |
| 46 |
|
Summit Therapeutics | SMMT | $19.53 B | $26.30 | 1.64% | UK |
| 47 |
|
Akeso | 9926.HK | $19.29 B | $21.50 | 3.32% | China |
| 48 |
|
Divis Laboratories | DIVISLAB.NS | $18.33 B | $69.06 | 0.38% | India |
| 49 |
|
Sichuan Biokin Pharmaceutical | 688506.SS | $18.14 B | $45.26 | 4.21% | China |
| 50 |
|
Sino Biopharmaceutical | 1177.HK | $17.67 B | $0.99 | 3.49% | China |
| 51 |
|
West Pharmaceutical | WST | $17.45 B | $242.81 | 1.45% | USA |
| 52 |
|
Incyte | INCY | $16.91 B | $86.62 | 0.49% | USA |
| 53 |
|
WuXi Biologics | WXXWY | $16.14 B | $7.98 | 2.31% | China |
| 54 |
|
Alteogen | 196170.KQ | $15.42 B | $289.43 | 3.68% | S. Korea |
| 55 |
|
CSPC Pharmaceutical Group Limited | 1093.HK | $15.33 B | $1.34 | 1.35% | China |
| 56 |
|
Genmab | GMAB | $14.99 B | $24.36 | 1.27% | Denmark |
| 57 |
|
Shionogi | 4507.T | $14.91 B | $17.52 | 1.89% | Japan |
| 58 |
|
Cipla | CIPLA.NS | $14.74 B | $18.25 | 3.02% | India |
| 59 |
|
Torrent Pharmaceuticals | TORNTPHARM.NS | $14.14 B | $41.79 | 0.45% | India |
| 60 |
|
United Therapeutics | UTHR | $14.00 B | $309.75 | 1.07% | USA |
| 61 |
|
ICON plc | ICLR | $13.60 B | $174.94 | 2.95% | Ireland |
| 62 |
|
Neurocrine Biosciences | NBIX | $13.44 B | $135.51 | 1.71% | USA |
| 63 |
|
Medpace | MEDP | $12.82 B | $456.63 | 1.95% | USA |
| 64 |
|
Viatris | VTRS | $12.46 B | $10.70 | 0.42% | USA |
| 65 |
|
Recordati | REC.MI | $12.41 B | $60.53 | 0.67% | Italy |
| 66 |
|
Baxter | BAX | $12.36 B | $24.07 | 0.82% | USA |
| 67 |
|
Dr. Reddy's Laboratories | RDY | $12.12 B | $14.40 | 1.88% | India |
| 68 |
|
Mankind Pharma | MANKIND.NS | $11.93 B | $29.79 | 3.73% | India |
| 69 |
|
Ascendis Pharma | ASND | $11.79 B | $194.76 | 1.02% | Denmark |
| 70 |
|
Zydus Lifesciences | ZYDUSLIFE.NS | $11.36 B | $11.29 | 0.25% | India |
| 71 |
|
Orion Corporation | ORNAV.HE | $11.30 B | $79.93 | 0.43% | Finland |
| 72 |
|
Ipsen | IPN.PA | $11.17 B | $135.12 | 0.61% | France |
| 73 |
|
Huadong Medicine (HD Medicine) | 000963.SZ | $11.16 B | $6.37 | 0.20% | China |
| 74 |
|
BioMarin Pharmaceutical | BMRN | $11.14 B | $58.04 | 0.14% | USA |
| 75 |
|
Caris Life Sciences | CAI | $10.65 B | $37.87 | 7.98% | USA |
| 76 |
|
Walgreens Boots Alliance | WBA | $10.59 B | $12.24 | 0.37% | USA |
| 77 |
|
Exelixis | EXEL | $10.42 B | $38.71 | 2.25% | USA |
| 78 |
|
Lupin Limited | LUPIN.NS | $10.27 B | $22.48 | 1.14% | India |
| 79 |
|
Moderna | MRNA | $10.24 B | $26.33 | 2.08% | USA |
| 80 |
|
Swedish Orphan Biovitrum | SOBI.ST | $10.24 B | $29.73 | 0.63% | Sweden |
| 81 |
|
CSPC Innovation Pharmaceutical | 300765.SZ | $9.80 B | $6.98 | 2.10% | China |
| 82 |
|
Fosun Pharma | 600196.SS | $9.71 B | $3.89 | 0.50% | China |
| 83 |
|
BridgeBio Pharma | BBIO | $9.53 B | $49.88 | 2.05% | USA |
| 84 |
|
kyowa Kirin | 4151.T | $9.28 B | $17.74 | 0.74% | Japan |
| 85 |
|
Haisco Pharmaceutical Group | 002653.SZ | $9.17 B | $8.19 | 0.14% | China |
| 86 |
|
Madrigal Pharmaceuticals | MDGL | $9.04 B | $405.94 | 3.64% | USA |
| 87 |
|
Verona Pharma | VRNA | $8.95 B | $105.43 | 0.35% | UK |
| 88 |
|
Eisai | 4523.T | $8.81 B | $31.26 | 2.09% | Japan |
| 89 |
|
Elanco | ELAN | $8.71 B | $17.55 | 0.52% | USA |
| 90 |
|
Grifols | GRFS | $8.65 B | $10.11 | 0.35% | Spain |
| 91 |
|
Bio-Techne | TECH | $8.49 B | $54.21 | 0.22% | USA |
| 92 |
|
Halozyme Therapeutics | HALO | $8.41 B | $71.96 | 1.16% | USA |
| 93 |
|
Financière de Tubize | TUB.BR | $8.33 B | $187.29 | 1.77% | Belgium |
| 94 |
|
Roivant Sciences | ROIV | $8.04 B | $11.78 | 0.51% | UK |
| 95 |
|
Shenzhen Salubris Pharmaceuticals | 002294.SZ | $7.96 B | $7.14 | 2.09% | China |
| 96 |
|
Abbott India | ABBOTINDIA.NS | $7.95 B | $373.89 | 0.12% | India |
| 97 |
|
Sinopharm | 1099.HK | $7.85 B | $2.52 | 0.15% | China |
| 98 |
|
Zhifei Biological Products | 300122.SZ | $7.72 B | $3.23 | 0.47% | China |
| 99 |
|
Corcept Therapeutics | CORT | $7.47 B | $70.90 | 0.71% | USA |
| 100 |
|
Alkem Laboratories | ALKEM.NS | $7.42 B | $62.12 | 0.54% | India |
Largest pharma companies by market capitalization
*This list highlights the leading companies in this category, ranked by their market value. Only publicly traded companies are included, since private companies don’t share enough financial details to estimate their value.
Market capitalization (or market cap) is the total value of a public company. It’s usually calculated by multiplying the company’s share price by the number of shares available.
Stock prices may not always be live and can be delayed from a few minutes to several hours.
All company logos are owned by their respective copyright holders and are shown here for editorial use only.
